HEMATOLOGICAL MALIGNANCIES
Clinical trials for HEMATOLOGICAL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCIES trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New transplant method aims to tame dangerous side effects
Disease control Not yet recruitingThis pilot study is testing a new method for stem cell transplants in adults with high-risk blood cancers who don't have a perfectly matched donor. The method uses a specially processed graft from a half-matched (haploidentical) donor, aiming to reduce the risk of severe graft-ve…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: NA • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated Apr 01, 2026 21:53 UTC
-
Engineered 'Super Cells' tested to fight rare, aggressive blood cancers
Disease control Not yet recruitingThis study tests a new cell therapy for adults with aggressive T-cell blood cancers who are in their first remission. Researchers will give patients specially engineered natural killer (NK) immune cells designed to target cancer, along with chemotherapy. The main goals are to see…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Scientists test mRNA tech to fight tough blood cancers
Disease control Not yet recruitingThis early study is testing a new mRNA-based injection called WGb-0302 for patients with blood cancers like multiple myeloma that have returned or stopped responding to standard treatments. The treatment uses technology similar to some COVID-19 vaccines to deliver instructions th…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: Sichuan University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
One-Shot cancer treatment? new injection reprograms immune cells inside the body
Disease control Not yet recruitingThis early study is testing a new, more accessible form of CAR-T therapy for adults with certain B-cell blood cancers, like leukemia and lymphoma. Instead of the complex process of removing and modifying a patient's cells in a lab, this experimental treatment is given as an injec…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC